Salmon calcitonin in the treatment of postmenopausal osteoporosis

V. Fatourechi, H. Heath

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.

Original languageEnglish (US)
Pages (from-to)923-925
Number of pages3
JournalAnnals of internal medicine
Issue number6
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Salmon calcitonin in the treatment of postmenopausal osteoporosis'. Together they form a unique fingerprint.

Cite this